Vanda Pharmaceuticals Inc (VNDA)
3.89
+0.03
(+0.78%)
USD |
NASDAQ |
Mar 27, 16:00
3.94
+0.05
(+1.29%)
Pre-Market: 08:14
Vanda Pharmaceuticals Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2021 | 3.55M |
September 30, 2021 | 3.941M |
June 30, 2021 | 3.693M |
March 31, 2021 | 7.004M |
December 31, 2020 | 5.634M |
September 30, 2020 | 6.318M |
June 30, 2020 | 6.753M |
March 31, 2020 | 6.564M |
December 31, 2019 | 6.264M |
September 30, 2019 | 4.94M |
June 30, 2019 | 4.494M |
March 31, 2019 | 3.571M |
December 31, 2018 | 107.13M |
September 30, 2018 | 106.42M |
June 30, 2018 | 107.07M |
March 31, 2018 | 106.78M |
December 31, 2017 | 5.251M |
September 30, 2017 | 5.92M |
June 30, 2017 | 11.11M |
March 31, 2017 | 9.936M |
December 31, 2016 | 7.751M |
September 30, 2016 | 7.00M |
June 30, 2016 | 4.617M |
March 31, 2016 | 4.194M |
December 31, 2015 | 4.091M |
Date | Value |
---|---|
September 30, 2015 | 91.58M |
June 30, 2015 | 88.20M |
March 31, 2015 | 87.64M |
December 31, 2014 | 89.73M |
September 30, 2014 | 2.682M |
June 30, 2014 | 51.30M |
March 31, 2014 | 52.06M |
December 31, 2013 | 49.86M |
September 30, 2013 | 49.43M |
June 30, 2013 | 0.613M |
March 31, 2013 | -0.181M |
December 31, 2012 | 0.012M |
September 30, 2012 | 0.02M |
June 30, 2012 | 0.025M |
March 31, 2012 | 0.025M |
December 31, 2011 | 0.025M |
September 30, 2011 | 1.352M |
June 30, 2011 | 1.389M |
March 31, 2011 | 1.851M |
December 31, 2010 | 3.784M |
September 30, 2010 | 2.772M |
June 30, 2010 | 3.131M |
March 31, 2010 | 3.552M |
December 31, 2009 | 1.619M |
September 30, 2009 | 1.284M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
3.55M
Minimum
Dec 2021
7.004M
Maximum
Mar 2021
5.227M
Average
5.287M
Median
Cash from Financing (TTM) Benchmarks
ADMA Biologics Inc | -38.99M |
Johnson & Johnson | -15.82B |
Nektar Therapeutics | 0.03M |
Amicus Therapeutics Inc | 61.68M |
CASI Pharmaceuticals Inc | -- |